Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice.
about
PEGylated Adenoviruses: From Mice to MonkeysPersistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectorsTowards fibroid gene therapy: adenovirus-mediated delivery of herpes simplex virus 1 thymidine kinase gene/ganciclovir shrinks uterine leiomyoma in the Eker rat model.Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model.Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits.A replication-incompetent adenovirus vector with the preterminal protein gene deleted efficiently transduces mouse earsAdeno-associated virus vectors and hematologyIn vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.Circumvention of immunity to the adenovirus major coat protein hexon.Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice.Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organsOvine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivoRegulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3.Gene therapy for hemophilia.The Current Status of Gene Therapy for Prostate Cancer.Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disordersNoninvasive imaging of lipid nanoparticle-mediated systemic delivery of small-interfering RNA to the liver.Myoblast transfer of human erythropoietin gene in a mouse model of renal failureHaemophilias: advances towards genetic engineering replacement therapy.Delivery of novel macromolecular drugs against HIV-1.Controlled induction of DNA double-strand breaks in the mouse liver induces features of tissue ageing.Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expressionConditional bicistronic Cre reporter line expressing both firefly luciferase and β-galactosidaseCombination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis.Strong foreign promoters contribute to innate inflammatory responses induced by adenovirus transducing vectors.Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectorsCellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenovirusesRole of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs.In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy.Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus.Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus.Adenoviral vectors: development and application.Development of approaches to improve cell survival in myoblast transfer therapy.Hepatocyte gene therapy in a large animal: a neonatal bovine model of citrullinemiaAdministration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboonsThe Gordon Wilson Lecture. In vivo gene therapy: a strategy to use human genes as therapeuticsE1A and E1B proteins inhibit inflammation induced by adenovirus.
P2860
Q24635276-E8786DC1-6527-4851-8BC3-BE4FB955B7EBQ24683259-C8178CDA-DF62-4C30-851C-C81E58266695Q30395754-0F9D1C7E-378A-4563-957C-03BDC99B8B1EQ30477786-A50593B2-28B9-425C-9DAE-C296057ECE35Q33331929-1B378910-435B-49B7-BEDD-4D0B9E382F63Q33640285-A840B432-5776-4245-AB72-2447462C09FAQ33695816-2AB34EDC-E4ED-4063-B969-DC345500BD0FQ33782356-C7CD4634-239C-489C-8F2C-B2AE7444A431Q33783658-4179592F-73D9-423C-AA8D-DF6AEC6A071CQ33813779-DF78CC34-1A5A-45D1-8EB3-31A3CA12955DQ33815920-9878B42B-E26C-4A1C-8CED-F581F65A20B3Q33817535-CE218AB4-13FF-4924-84DD-3AFB875D6D48Q33817933-4E06C59A-2488-4CA3-BA74-35D004E8E8B1Q33819873-0E1AD9AE-797A-4EBF-87F7-5DA2EC811D81Q33838660-61CBF444-0E41-4859-BE72-58D0F61392A4Q33889283-BDAF0E92-0A2A-4BC0-9E99-BD140E44E78CQ33985663-81B40BC7-B45B-4784-BAFD-5A9C85A013C3Q34209742-299A1EB5-65FD-4560-9DE9-AF960901557CQ34210746-2147FCAF-03D7-4A20-8D7E-9621BAAD9378Q34229310-0BC7CBD5-21DE-4FF1-BF15-9B769022C3E9Q34452681-4631085D-3A7A-4FEE-8220-2C3AA90F0510Q34470994-C8D7495F-11EA-4FC4-A8A5-116523DC5F44Q34615481-F147AB5B-523F-4F45-B443-9F6320436382Q34634681-FEEC2EE8-C1B6-46AB-9080-E774F7C35889Q34982831-E5BEE612-2948-4966-9F66-65AD053F91B3Q35553022-FF5DCFDA-D71D-43A8-8CF5-D403A3E41AC7Q35568410-0CF2E84B-663C-4BBA-B317-3B4212FB69DAQ35763533-ED4137CE-E277-4F79-9715-DC404FEF0DDEQ35837026-7235FD79-4F6F-45BA-91F6-8AABDBD9346AQ35871002-CB5A04F7-3280-4C36-9D7C-B917BFF1B510Q35871957-15DCCEDA-C2F5-4D59-9967-835B8146B330Q35874183-2A149C4B-DDD7-4B80-AE44-BEAE6AF37BC2Q35922620-F9D024B7-3247-476E-9EFF-645996E70E57Q36159178-516F3B84-65A4-4EC4-95C1-7B8AFA6D2CA6Q36179657-DC0E904C-BEF9-4F4C-8F31-F19B748AF78DQ36290641-A3AB7E77-E366-436A-88CE-1F72767A1415Q36455873-BD04060A-6E05-4966-80A3-073BDB61FE4AQ36557727-A60623B0-882B-4663-B02E-5F7051E54A7AQ36647187-2836B5CE-C312-494A-A3E5-04D19E1CA147Q36854089-0DF075E5-75B5-456B-AD58-C9646B44E997
P2860
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice.
@en
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice.
@nl
type
label
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice.
@en
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice.
@nl
prefLabel
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice.
@en
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice.
@nl
P2093
P356
P1433
P1476
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice.
@en
P2093
McClelland A
Mehaffey MG
Saunders JM
Trapnell BC
P2888
P304
P356
10.1038/NG1293-397
P407
P577
1993-12-01T00:00:00Z
P6179
1012339522